22 47

Cited 0 times in

Novel Therapeutic Effects of Pterosin B on Ang II-Induced Cardiomyocyte Hypertrophy

DC FieldValueLanguage
dc.contributor.author박한기-
dc.date.accessioned2021-01-19T08:00:46Z-
dc.date.available2021-01-19T08:00:46Z-
dc.date.issued2020-11-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/181424-
dc.description.abstractPathological cardiac hypertrophy is characterized by an abnormal increase in cardiac muscle mass in the left ventricle, resulting in cardiac dysfunction. Although various therapeutic approaches are being continuously developed for heart failure, several studies have suggested natural compounds as novel potential strategies. Considering relevant compounds, we investigated a new role for Pterosin B for which the potential life-affecting biological and therapeutic effects on cardiomyocyte hypertrophy are not fully known. Thus, we investigated whether Pterosin B can regulate cardiomyocyte hypertrophy induced by angiotensin II (Ang II) using H9c2 cells. The antihypertrophic effect of Pterosin B was evaluated, and the results showed that it reduced hypertrophy-related gene expression, cell size, and protein synthesis. In addition, upon Ang II stimulation, Pterosin B attenuated the activation and expression of major receptors, Ang II type 1 receptor and a receptor for advanced glycation end products, by inhibiting the phosphorylation of PKC-ERK-NF-κB pathway signaling molecules. In addition, Pterosin B showed the ability to reduce excessive intracellular reactive oxygen species, critical mediators for cardiac hypertrophy upon Ang II exposure, by regulating the expression levels of NAD(P)H oxidase 2/4. Our results demonstrate the protective role of Pterosin B in cardiomyocyte hypertrophy, suggesting it is a potential therapeutic candidate.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherMDPI-
dc.relation.isPartOfMOLECULES-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleNovel Therapeutic Effects of Pterosin B on Ang II-Induced Cardiomyocyte Hypertrophy-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Thoracic and Cardiovascular Surgery (흉부외과학교실)-
dc.contributor.googleauthorChang Youn Lee-
dc.contributor.googleauthorHan Ki Park-
dc.contributor.googleauthorBok-Sim Lee-
dc.contributor.googleauthorSeongtae Jeong-
dc.contributor.googleauthorSung-Ae Hyun-
dc.contributor.googleauthorJung-Won Choi-
dc.contributor.googleauthorSang Woo Kim-
dc.contributor.googleauthorSeahyoung Lee-
dc.contributor.googleauthorSoyeon Lim-
dc.contributor.googleauthorKi-Chul Hwang-
dc.identifier.doi10.3390/molecules25225279-
dc.contributor.localIdA01729-
dc.relation.journalcodeJ03201-
dc.identifier.eissn1420-3049-
dc.identifier.pmid33198253-
dc.subject.keywordPterosin B-
dc.subject.keywordangiotensin II-
dc.subject.keywordcardiomyocyte hypertrophy-
dc.contributor.alternativeNamePark, Han Ki-
dc.contributor.affiliatedAuthor박한기-
dc.citation.volume25-
dc.citation.number22-
dc.citation.startPage5279-
dc.identifier.bibliographicCitationMOLECULES, Vol.25(22) : 5279, 2020-11-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Thoracic and Cardiovascular Surgery (흉부외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.